Navigation Links
Midwest is cost-effective for startup biotech companies

In May 2003, I wrote a column about the cost of doing business (CODB) for biotech companies in different parts of the United States. The point of the column was that one of the advantages of doing business in the Midwest is a significant cost advantage versus setting up shop in other parts of the country (or even the world).

We know that the cost of wet lab ......

Full article >>> of the biotech industry.

I will warn you in advance that I'm not going to include all 50 cities. Instead, I'm giving you a sampling of cities.

In all fairness to the European cities listed here, part of their high cost is the increased valuation of the Euro against the U.S. dollar. The U.S. dollar is currently worth about 80 percent of one Euro. The value of the Euro has increase......

Full article >>> raise more money may outweigh the higher CODB. San Diego is probably the most cost-effective place as the CODB is about the same as Chicago but with a greater ability to raise VC funds. In the Midwest, Minneapolis is clearly king when you factor in CODB and ability to raise VC money.

When I started this column back in February 2003, I did so under the firm belief that no individual was c......

Full article >>> or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 02/21/05


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
Breaking Biology News(10 mins):